February 27, 2024 Comments Off on New patent for Novartis drug TAFINLAR Posted in: Patent Added Annual Drug Patent Expirations for TAFINLAR Tafinlar is a drug marketed by Novartis and is included in two NDAs. It is available from one supplier. There are twelve patents protecting…
The post New patent for Novartis drug TAFINLAR appeared first on Dr…
February 27, 2024 Comments Off on New patent for Biogen Inc drug ZURZUVAE Posted in: Patent Added Annual Drug Patent Expirations for ZURZUVAE Zurzuvae is a drug marketed by Biogen Inc and is included in one NDA. It is available from one supplier. There are four patents…
The post New patent for Biogen Inc drug ZURZUVAE appeared first on DrugPatentWa…
